Overview

Preemptive Analgesia for Primary Dysmenorrhoea

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Preemptive analgesia before the release of pain mediators
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hanan Nabil
Treatments:
Mefenamic Acid